Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing

NCT07254442 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2025-11-28

No results posted yet for this study

Summary

Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing

Conditions

  • Hearing
  • COVID - 19
  • Ototoxicity

Interventions

DIAGNOSTIC_TEST

Hearing tests

Participants' pure tone thresholds, high frequency thresholds, and otoacoustic emissions measurements were evaluated.

Sponsors & Collaborators

  • Zonguldak Bulent Ecevit University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-02-01
Completion
2022-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07254442 on ClinicalTrials.gov